About: http://webisa.webdatacommons.org/374796516

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Since 2000, biotherapeutic approaches targeting inflammatory cytokines, such as the tumour necrosis factor (TNF)-alpha inhibitor Etanercept, have revolutionised the management and prognosis of severe forms of the disease.
http://www.w3.org/ns/prov#wasQuotedFrom	orpha.net